{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT04053270","recordId":"NCT04053270","peptideSlug":"afamelanotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04053270-afamelanotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct04053270.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct04053270.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":["Adverse Events","Baseline Characteristics","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","References","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2019-10-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"afamelanotide","submittedDate":"2019-10-08","publishedAt":"2026-08-23","recordId":"NCT04053270","recordSha256":"1c20b67e7742c9486f9ddcda5f72ecbc3db7d5cea308a6ef80b5f72398298710","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04053270?a=2&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"cb55c85185e3ae992aa0ad24fb458b403540fe13db0fc11b2af71e5b5c4d5440"}}